Join the conversation, use hashtag #BioPharmaDeals2022 and mention Clarivate for Life Sciences & Healthcare on Twitter and LinkedIn.
Methodology for the Report
Clarivate technology and experts harmonize billions of datapoints from thousands of sources and provide a unified view to drive decision-making for a variety of use cases, including deal-making, forecasting, portfolio strategy and more. Leveraging data and insights from BioWorld™ and Cortellis Deals Intelligence™, as well as a proprietary, predictive analytics which draw on more than 20 traits from across the entire body of Cortellis data, including 110,000+ life sciences deals, 36,000+ contracts and 9,500+ unredacted contracts, Clarivate drew upon technology and expertise to harmonize datapoints from multiple sources to provide a unified view of deal-making in 2021 and potential implications.
About Clarivate Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.